NovaBridge Biosciences Financing Cash Flow
NovaBridge Biosciences (NBP) reported Financing Cash Flow of CNY 7.57 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-04-30
- NovaBridge Biosciences net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was 844.79M CNY, a 645.65% increase year-over-year.
- NovaBridge Biosciences net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was 113.30M CNY.
CNY
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | 7.57M CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 42.36M CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 35.38M CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 593.92M CNY 20-F · filed 2024-04-30 | |||
| 2021-06-30 | 486.24M CNY 6-K · filed 2022-11-10 | |||
| 2020-12-31 | 844.79M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 3.44B CNY 20-F · filed 2023-05-01 | ||
| 2020-09-30 | 2.60B CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 113.30M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 152.71M CNY 20-F · filed 2022-04-29 | ||
| 2019-09-30 | 39.41M CNY 6-K · filed 2021-02-05 | |||
| 2018-12-31 | 1.48B CNY 20-F · filed 2021-04-28 | |||
| 2017-12-31 | 758.59M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.07M 20-F · filed 2024-04-30 | |||
| 2022-12-31 | $6.14M 20-F · filed 2023-05-01 | |||
| 2022-06-30 | $5.28M 6-K · filed 2022-11-10 | |||
| 2021-12-31 | $93.20M 20-F · filed 2022-04-29 | |||
| 2020-12-31 | $144.97M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $527.28M 20-F · filed 2021-04-28 | ||
| 2020-09-30 | $382.30M 6-K · filed 2021-02-05 | |||
| 2019-12-31 | $21.94M 20-F · filed 2020-04-29 |